Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
2021-005550-28Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in acute coronary syndrome (ACS), sponsored by Amsterdam University Medical Center. Primary endpoint: Primary bleeding endpoint at 12 months. Started Feb 2022; status: active.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2021-005550-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005550-28.